ArticleAmerican journal of cancer research2025
Enhanced inhibitory effects of mianserin in combination with sorafenib on liver cancer growth through targeting the CCR9-AKT pathway.
Ya-Hui Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.